Gen-Probe Submits PMA to FDA for HPV Assay | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe has submitted an application with the US Food and Drug Administration for regulatory approval of a genotyping assay for human papillomavirus.

A spokesman for the San Diego-based company today confirmed the PMA submission. The assay will run on the Tigris system and will detect for type 16 alone and type 18/45 together. The spokesman declined to comment about when a decision from FDA is expected.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.